Lpl Financial LLC Catalent, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 8,455 shares of CTLT stock, worth $536,723. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,455

Previous 19,211 55.99%

Holding current value

$536,723

Previous $1.08 Million 52.59%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$56.16 - $60.96 $604,056 - $655,685	-10,756 Reduced 55.99%	8,455 $512,000
Q2 2024 Aug 07, 2024	SELL	$53.58 - $57.02 $389,794 - $414,820	-7,275 Reduced 27.47%	19,211 $1.08 Million
Q1 2024 May 10, 2024	SELL	$42.56 - $59.82 $853,030 - $1.2 Million	-20,043 Reduced 43.08%	26,486 $1.5 Million
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $195,976 - $283,611	-6,090 Reduced 11.57%	46,529 $2.09 Million
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $1.8 Million - $2.04 Million	40,661 Added 340.03%	52,619 $2.4 Million
Q2 2023 Jul 31, 2023	SELL	$31.86 - $67.26 $6,977 - $14,729	-219 Reduced 1.8%	11,958 $518,000
Q1 2023 May 10, 2023	BUY	$45.44 - $74.26 $553,322 - $904,264	12,177 New	12,177 $800,000
Q3 2022 Nov 14, 2022	SELL	$72.36 - $113.1 $168,671 - $263,636	-2,331 Reduced 22.15%	8,191 $593,000
Q2 2022 Aug 12, 2022	SELL	$87.2 - $114.05 $377,750 - $494,064	-4,332 Reduced 29.16%	10,522 $1.13 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $200,342 - $264,790	2,127 Added 16.71%	14,854 $1.65 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $358,351 - $416,792	2,997 Added 30.8%	12,727 $1.63 Million
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $422,051 - $550,325	3,866 Added 65.93%	9,730 $1.3 Million
Q2 2021 Aug 13, 2021	SELL	$100.34 - $115.69 $31,908 - $36,789	-318 Reduced 5.14%	5,864 $634,000
Q1 2021 May 14, 2021	BUY	$101.51 - $125.27 $13,703 - $16,911	135 Added 2.23%	6,182 $651,000
Q4 2020 Feb 12, 2021	BUY	$85.88 - $105.36 $103,141 - $126,537	1,201 Added 24.78%	6,047 $629,000
Q3 2020 Nov 09, 2020	SELL	$72.74 - $92.5 $56,155 - $71,410	-772 Reduced 13.74%	4,846 $415,000
Q2 2020 Aug 13, 2020	BUY	$48.02 - $79.04 $24,586 - $40,468	512 Added 10.03%	5,618 $412,000
Q1 2020 May 14, 2020	BUY	$36.95 - $62.95 $5,136 - $8,750	139 Added 2.8%	5,106 $265,000
Q4 2019 Feb 14, 2020	SELL	$47.06 - $56.64 $148,380 - $178,585	-3,153 Reduced 38.83%	4,967 $280,000
Q3 2019 Nov 13, 2019	SELL	$47.45 - $58.05 $4,650 - $5,688	-98 Reduced 1.19%	8,120 $387,000
Q2 2019 Aug 09, 2019	BUY	$39.26 - $54.21 $322,638 - $445,497	8,218 New	8,218 $445,000
Q3 2018 Nov 14, 2018	SELL	$40.12 - $45.55 $269,084 - $305,503	-6,707 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$38.72 - $42.52 $34,848 - $38,268	-900 Reduced 11.83%	6,707 $281,000
Q1 2018 May 15, 2018	BUY	$39.4 - $47.39 $2,009 - $2,416	51 Added 0.67%	7,607 $311,000
Q4 2017 Feb 14, 2018	BUY	$37.27 - $43.02 $3,167 - $3,656	85 Added 1.14%	7,556 $311,000
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $252,146 - $311,316	7,471	7,471 $298,000

Others Institutions Holding CTLT

# of Institutions

509

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Catalent, Inc. Transaction History